Recombinant DNA Technology Market
Recombinant DNA Technology Market - Global Industry Assessment & Forecast
Segments Covered
- By Products Medical, Non-Medical
- By Components Expression System, Cloning Vector
- By Applications Food & Agriculture, Health & Disease, Environment, Other Applications
- By End Users Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other End Users
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 152.79 Billion |
Revenue 2030: | USD 274.52 Billion |
Revenue CAGR (2023 - 2030): | 7.60% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Recombinant DNA Technology Market - Segment Analysis
- Overview
- Global Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
Global Recombinant DNA Technology Market - by Products
- By Medical
- By Non-Medical
-
Global Recombinant DNA Technology Market - by Components
- By Expression System
- By Cloning Vector
-
Global Recombinant DNA Technology Market - by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
Global Recombinant DNA Technology Market - by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
Global Recombinant DNA Technology Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Recombinant DNA Technology Market - Segment Analysis
- Overview
- North America Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
North America Recombinant DNA Technology Market, by Products
- By Medical
- By Non-Medical
-
North America Recombinant DNA Technology Market, by Components
- By Expression System
- By Cloning Vector
-
North America Recombinant DNA Technology Market, by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
North America Recombinant DNA Technology Market, by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
North America Recombinant DNA Technology Market, by Country
- U.S.
- U.S. Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- U.S. Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- U.S. Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- U.S. Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- U.S. Recombinant DNA Technology Market, By Products
- Canada
- Canada Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Canada Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Canada Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Canada Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Canada Recombinant DNA Technology Market, By Products
- Mexico
- Mexico Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Mexico Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Mexico Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Mexico Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Mexico Recombinant DNA Technology Market, By Products
- U.S.
-
Europe Recombinant DNA Technology Market - Segment Analysis
- Overview
- Europe Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
Europe Recombinant DNA Technology Market, by Products
- By Medical
- By Non-Medical
-
Europe Recombinant DNA Technology Market, by Components
- By Expression System
- By Cloning Vector
-
Europe Recombinant DNA Technology Market, by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
Europe Recombinant DNA Technology Market, by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
Europe Recombinant DNA Technology Market, by Country
- Germany
- Germany Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Germany Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Germany Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Germany Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Germany Recombinant DNA Technology Market, By Products
- UK
- UK Market, By Products
- By Medical
- By Non-Medical
- UK Market, By Components
- By Expression System
- By Cloning Vector
- UK Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- UK Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- UK Market, By Products
- France
- France Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- France Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- France Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- France Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- France Recombinant DNA Technology Market, By Products
- Spain
- Spain Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Spain Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Spain Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Spain Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Spain Recombinant DNA Technology Market, By Products
- Italy
- Italy Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Italy Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Italy Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Italy Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Italy Recombinant DNA Technology Market, By Products
- BENELUX
- BENELUX Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- BENELUX Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- BENELUX Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- BENELUX Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- BENELUX Recombinant DNA Technology Market, By Products
- Rest of Europe
- Rest Of Europe Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Rest Of Europe Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Rest Of Europe Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Rest Of Europe Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Rest Of Europe Recombinant DNA Technology Market, By Products
- Germany
-
Asia Pacific Recombinant DNA Technology Market - Segment Analysis
- Overview
- Asia Pacific Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
Asia Pacific Recombinant DNA Technology Market, by Products
- By Medical
- By Non-Medical
-
Asia Pacific Recombinant DNA Technology Market, by Components
- By Expression System
- By Cloning Vector
-
Asia Pacific Recombinant DNA Technology Market, by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
Asia Pacific Recombinant DNA Technology Market, by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
Asia Pacific Recombinant DNA Technology Market, by Country
- China
- China Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- China Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- China Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- China Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- China Recombinant DNA Technology Market, By Products
- Japan
- Japan Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Japan Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Japan Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Japan Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Japan Recombinant DNA Technology Market, By Products
- India
- India Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- India Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- India Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- India Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- India Recombinant DNA Technology Market, By Products
- South Korea
- South Korea Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- South Korea Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- South Korea Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- South Korea Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- South Korea Recombinant DNA Technology Market, By Products
- South East Asia
- South East Asia Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- South East Asia Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- South East Asia Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- South East Asia Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- South East Asia Recombinant DNA Technology Market, By Products
- Rest of Asia Pacific
- Rest of Asia Pacific Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Rest of Asia Pacific Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Rest of Asia Pacific Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Rest of Asia Pacific Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Rest of Asia Pacific Recombinant DNA Technology Market, By Products
- China
-
Latin America Recombinant DNA Technology Market - Segment Analysis
- Overview
- Latin America Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
Latin America Recombinant DNA Technology Market, by Products
- By Medical
- By Non-Medical
-
Latin America Recombinant DNA Technology Market, by Components
- By Expression System
- By Cloning Vector
-
Latin America Recombinant DNA Technology Market, by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
Latin America Recombinant DNA Technology Market, by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
Latin America Recombinant DNA Technology Market, by Country
- Brazil
- Brazil Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Brazil Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Brazil Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Brazil Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Brazil Recombinant DNA Technology Market, By Products
- Argentina
- Argentina Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Argentina Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Argentina Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Argentina Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Argentina Recombinant DNA Technology Market, By Products
- Rest of Latin America
- Rest of Latin America Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Rest of Latin America Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Rest of Latin America Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Rest of Latin America Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Rest of Latin America Recombinant DNA Technology Market, By Products
- Brazil
-
Middle East & Africa Recombinant DNA Technology Market - Segment Analysis
- Overview
- Middle East & Africa Recombinant DNA Technology Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Recombinant DNA Technology Market, by Products
- By Medical
- By Non-Medical
-
Middle East & Africa Recombinant DNA Technology Market, by Components
- By Expression System
- By Cloning Vector
-
Middle East & Africa Recombinant DNA Technology Market, by Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
-
Middle East & Africa Recombinant DNA Technology Market, by End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
-
Middle East & Africa Recombinant DNA Technology Market, by Country
- GCC Countries
- GCC Countries Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- GCC Countries Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- GCC Countries Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- GCC Countries Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- GCC Countries Recombinant DNA Technology Market, By Products
- South Africa
- South Africa Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- South Africa Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- South Africa Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- South Africa Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- South Africa Recombinant DNA Technology Market, By Products
- Rest of Middle East & Africa
- Rest of Middle East & Africa Recombinant DNA Technology Market, By Products
- By Medical
- By Non-Medical
- Rest of Middle East & Africa Recombinant DNA Technology Market, By Components
- By Expression System
- By Cloning Vector
- Rest of Middle East & Africa Recombinant DNA Technology Market, By Applications
- By Food & Agriculture
- By Health & Disease
- By Environment
- By Other Applications
- Rest of Middle East & Africa Recombinant DNA Technology Market, By End Users
- By Biotechnology & Pharmaceutical Companies
- By Academic & Government Research Institutes
- By Other End Users
- Rest of Middle East & Africa Recombinant DNA Technology Market, By Products
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- F. Hoffmann-La Roche Ltd (Genentech Inc)
- Profacgen
- Amgen Inc
- Novartis AG
- GenScript
- Pfizer Inc
- Novo Nordisk A/S
- Eli Lilly and Company
- Sanofi Merck & Co. Inc.
- Biogen
- Biocon
- GlaxoSmithKline PLC
- New England Biolabs
- Cibus
- Monsanto Company
- Horizon Discovery Group PLC
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Recombinant DNA Technology in terms of revenue?
-
The global Recombinant DNA Technology valued at USD 152.79 Billion in 2022 and is expected to reach USD 274.52 Billion in 2030 growing at a CAGR of 7.60%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd (Genentech Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Merck & Co. Inc., Biogen, Biocon, GlaxoSmithKline PLC, New England Biolabs, Cibus, Monsanto Company, Horizon Discovery Group PLC.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Recombinant DNA Technology include
- Huge success of recombinant insulin
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Recombinant DNA Technology in 2022.